{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:22:26Z","timestamp":1792110146267,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,22]]},"DOI":"10.7759\/cureus.52731","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T15:22:55Z","timestamp":1705936975000},"source":"Crossref","is-referenced-by-count":1,"title":["A Prospective Observational Study on Clinical Profile and Visual Outcomes in Neovascular Age-Related Macular Degeneration"],"prefix":"10.7759","author":[{"given":"Ramamani","family":"Dalai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha S","family":"Bedant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Rout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijnya B","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.083733","article-title":"The epidemiology of age related eye diseases in Asia","volume":"90","author":"Wong TY","year":"2006","unstructured":"Wong TY, Loon SC, Saw SM. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol. 2006, 90:506-11. 10.1136\/bjo.2005.083733","journal-title":"Br J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890600946724","article-title":"Age-related macular degeneration--emerging pathogenetic and therapeutic concepts","volume":"38","author":"Gehrs KM","year":"2006","unstructured":"Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med. 2006, 38:450-71. 10.1080\/07853890600946724","journal-title":"Ann Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.091","article-title":"Age-related macular degeneration: genetic and clinical findings","volume":"49","author":"Kokotas H","year":"2011","unstructured":"Kokotas H, Grigoriadou M, Petersen MB. Age-related macular degeneration: genetic and clinical findings. Clin Chem Lab Med. 2011, 49:601-16. 10.1515\/CCLM.2011.091","journal-title":"Clin Chem Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031170","article-title":"Neovascular macular degeneration: A review of etiology, risk factors, and recent advances in research and therapy","volume":"22","author":"Pugazhendhi A","year":"2021","unstructured":"Pugazhendhi A, Hubbell M, Jairam P, Ambati B. Neovascular macular degeneration: A review of etiology, risk factors, and recent advances in research and therapy. Int J Mol Sci. 2021, 22:1170. 10.3390\/ijms22031170","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-016-0063-5","article-title":"Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors","volume":"3","author":"Pennington KL","year":"2016","unstructured":"Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond). 2016, 3:34. 10.1186\/s40662-016-0063-5","journal-title":"Eye Vis (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong WL","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health.  2014, 2:e106-e116. 10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13343","article-title":"Role of diet and food intake in age-related macular degeneration: a systematic review","volume":"47","author":"Chapman NA","year":"2019","unstructured":"Chapman NA, Jacobs RJ, Braakhuis AJ. Role of diet and food intake in age-related macular degeneration: a systematic review. Clin Exp Ophthalmol. 2019, 47:106-27. 10.1111\/ceo.13343","journal-title":"Clin Exp Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4114","article-title":"Prevalence of early and late age-related macular degeneration in India: the INDEYE study","volume":"51","author":"Krishnan T","year":"2010","unstructured":"Krishnan T, Ravindran RD, Murthy GV, et al.. Prevalence of early and late age-related macular degeneration in India: the INDEYE study. Invest Ophthalmol Vis Sci. 2010, 51:701-7. 10.1167\/iovs.09-4114","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11122313","article-title":"Role of optical coherence tomography imaging in predicting progression of age-related macular disease: a survey","volume":"11","author":"Elsharkawy M","year":"2021","unstructured":"Elsharkawy M, Elrazzaz M, Ghazal M, et al.. Role of optical coherence tomography imaging in predicting progression of age-related macular disease: a survey. Diagnostics (Basel). 2021, 11:2313. 10.3390\/diagnostics11122313","journal-title":"Diagnostics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14299","article-title":"Nongenetic risk factors for neovascular age-related macular degeneration","volume":"55","author":"Ristau T","year":"2014","unstructured":"Ristau T, Ersoy L, Hahn M, den Hollander AI, Kirchhof B, Liakopoulos S, Fauser S. Nongenetic risk factors for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014, 55:5228-32. 10.1167\/iovs.14-14299","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2018-000257","article-title":"Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies","volume":"4","author":"Clearkin L","year":"2019","unstructured":"Clearkin L, Ramasamy B, Wason J, Tiew S. Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies. BMJ Open Ophthalmol. 2019, 4:e000257. 10.1136\/bmjophth-2018-000257","journal-title":"BMJ Open Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-73259-4_6","article-title":"Therapeutic anti-VEGF antibodies","author":"Lien S","year":"2008","unstructured":"Lien S, Lowman HB. Therapeutic anti-VEGF antibodies. Handb Exp Pharmacol. 2008, 131-50. 10.1007\/978-3-540-73259-4_6","journal-title":"Handb Exp Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767080-00007","article-title":"Ranibizumab","volume":"67","author":"Blick SK","year":"2007","unstructured":"Blick SK, Keating GM, Wagstaff AJ. Ranibizumab. Drugs. 2007, 67:1199-206. 10.2165\/00003495-200767080-00007","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.12.028","article-title":"The landmark Beaver Dam eye study ushered in modern epidemiologic research in age-related macular degeneration","volume":"127","author":"Chew EY","year":"2020","unstructured":"Chew EY. The landmark Beaver Dam eye study ushered in modern epidemiologic research in age-related macular degeneration. Ophthalmology. 2020, 127:S120-1. 10.1016\/j.ophtha.2019.12.028","journal-title":"Ophthalmology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.176025","article-title":"Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up","volume":"63","author":"Sudhalkar A","year":"2015","unstructured":"Sudhalkar A, Sethi V, Gogte P, Bondalapati S, Khodani M, Chhablani JK. Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up. Indian J Ophthalmol. 2015, 63:899-904. 10.4103\/0301-4738.176025","journal-title":"Indian J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/895147","article-title":"Smoking and age-related macular degeneration: review and update","volume":"2013","author":"Velilla S","year":"2013","unstructured":"Velilla S, Garc\u00eda-Medina JJ, Garc\u00eda-Layana A, et al.. Smoking and age-related macular degeneration: review and update. J Ophthalmol. 2013, 2013:895147. 10.1155\/2013\/895147","journal-title":"J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. age-related macular degeneration risk Ffctors study group","volume":"118","author":"Hyman L","year":"2000","unstructured":"Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. age-related macular degeneration risk Ffctors study group. Arch Ophthalmol. 2000, 118:351-8. 10.1001\/archopht.118.3.351","journal-title":"Arch Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood SS","year":"2014","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014, 383:999-1008. 10.1016\/S0140-6736(13)61752-3","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S231913","article-title":"Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options","volume":"16","author":"Tan CS","year":"2022","unstructured":"Tan CS, Ngo WK, Chay IW, Ting DS, Sadda SR. Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options. Clin Ophthalmol. 2022, 16:917-33. 10.2147\/OPTH.S231913","journal-title":"Clin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002670","article-title":"Ranibizumab treatment in treatment-naive neovascular age-related macular degeneration: results from LUMINOUS, a global real-world study","volume":"40","author":"Holz FG","year":"2020","unstructured":"Holz FG, Figueroa MS, Bandello F, et al.. Ranibizumab treatment in treatment-naive neovascular age-related macular degeneration: results from LUMINOUS, a global real-world study. Retina. 2020, 40:1673-85. 10.1097\/IAE.0000000000002670","journal-title":"Retina"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.050","article-title":"The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study","volume":"119","author":"Klein BE","year":"2012","unstructured":"Klein BE, Howard KP, Lee KE, Iyengar SK, Sivakumaran TA, Klein R. The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2012, 119:1628-33. 10.1016\/j.ophtha.2012.01.050","journal-title":"Ophthalmology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.36475","article-title":"Role of ranibizumab in management of macular degeneration","volume":"55","author":"Singh RP","year":"2007","unstructured":"Singh RP, Kaiser PK. Role of ranibizumab in management of macular degeneration. Indian J Ophthalmol. 2007, 55:421-5. 10.4103\/0301-4738.36475","journal-title":"Indian J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld PJ","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006, 355:1419-31. 10.1056\/NEJMoa054481","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s1959","article-title":"Treatment of age-related macular degeneration: focus on ranibizumab","volume":"2","author":"Spitzer MS","year":"2008","unstructured":"Spitzer MS, Ziemssen F, Bartz-Schmidt KU, Gelisken F, Szurman P. Treatment of age-related macular degeneration: focus on ranibizumab. Clin Ophthalmol. 2008, 2:1-14. 10.2147\/opth.s1959","journal-title":"Clin Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.01.024","article-title":"A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study","volume":"148","author":"Lalwani GA","year":"2009","unstructured":"Lalwani GA, Rosenfeld PJ, Fung AE, et al.. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol. 2009, 148:43-58.e1. 10.1016\/j.ajo.2009.01.024","journal-title":"Am J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/190914-a-prospective-observational-study-on-clinical-profile-and-visual-outcomes-in-neovascular-age-related-macular-degeneration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:43Z","timestamp":1707509623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/190914-a-prospective-observational-study-on-clinical-profile-and-visual-outcomes-in-neovascular-age-related-macular-degeneration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.52731","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}